Through the combination of complementary technology, product portfolios and manufacturing capabilities, the acquisition of Dharmacon by Horizon creates an emerging leader in the application of gene modulation technologies in life science research. We expect that the brand recognition, and sales, marketing (including eCommerce) and distribution channel particularly in the academic community as well as intimate relationships in Biotech and Pharma that Dharmacon will bring to Horizon, will transform the opportunity for Horizon’s product portfolio as well as generate attractive cost-base synergies.
Chief Executive Officer | Horizon Discovery
As leaders in custom RNA synthesis, Dharmacon Inc was an early participant in the newly discovered field of RNA interference, and contributed several key scientific findings and some of the first commercially available, guaranteed to-silence siRNA reagents. This leadership continued through technical advances in bioinformatics and chemical modifications to improve performance. Today, our areas of research and research tools have expanded to support all aspects of RNAi interference; siRNA, lentiviral shRNA, tools for microRNA research and genome scale libraries for RNAi functional screens of genes, microRNAs and long non-coding RNAs. For over-expression, GE Healthcare has one of the largest collections of cDNAs and ORFs commercially available.
information is collected
Negotiation and Agreement
Both organizations begin formulating an Agreement as Due Diligence information is collected.
Announcement Planning/ Announcement
Announcement Planning begins as soon as there is a significant probability that the deal will be completed
External Regulatory Approval
Various regulatory approvals are required for a deal to be finalized.
Once all regulatory approvals have been received and all parties have met the terms and conditions of the Definitive Purchase Agreement, the deal can be closed.
by developing and providing innovative, high quality RNA/DNA products, tools, and support for any application from basic research tools to pre-clinical development
Advanced gene editing and gene modulation tools for life science research and drug discovery
Individual gene analysis
High titer viral particles
Proprietary 5-plasmid technology
Genome-scale screening reagents
Find us on Google Maps here
F.A.O K. Bailey, Horizon Discovery, Waterbeach, Cambridge
+44 (0)1223 976000